VELOCIMED
Velocimed was founded by a group of well known medical entrepreneurs. The company's founders envisioned a company that would become a global leader in the identification and development of innovative technologies with the power to improve the lives of patients whose clinical needs are not being met. Lead by a seasoned management team, Velocimed creates products internally and also looks externally for new technologies by partnering with physicians, inventors and institutions -- particularly t... hose who may lack access to the necessary resources required for early development of new ideas. At Velocimed, they believe that they own a unique position in medical innovation and commercialization. Unlike small incubators, they have the expertise to commercialize viable technology. And unlike large companies, they have the ability to pinpoint opportunities faster and move more quickly.
VELOCIMED
Industry:
Health Care Medical Medical Device
Founded:
2003-01-01
Address:
Minneapolis, Minnesota, United States
Country:
United States
Total Employee:
11+
Status:
Active
Contact:
(763) 463-4700
Email Addresses:
[email protected]
Total Funding:
34.5 M USD
Similar Organizations
Life Assure
Life Assure is a provider of medical alert systems for elders.
Founder
Investors List
RiverVest
RiverVest investment in Series D - Velocimed
Warburg Pincus
Warburg Pincus investment in Series D - Velocimed
The Vertical Group
The Vertical Group investment in Series D - Velocimed
Arnerich Massena & Associates
Arnerich Massena & Associates investment in Series D - Velocimed
RiverVest
RiverVest investment in Series C - Velocimed
Warburg Pincus
Warburg Pincus investment in Series C - Velocimed
The Vertical Group
The Vertical Group investment in Series C - Velocimed
More informations about "Velocimed" on Search Engine
Velocimed Company Profile: Valuation, Investors, Acquisition
Velocimed is headquartered in Osseo, MN. What industry is Velocimed in? Velocimed’s primary industry is Surgical Devices. Is Velocimed a private or public company? …See details»
St. Jude Medical Announces Agreement To Acquire Velocimed
Feb 16, 2005 St. Jude Medical, Inc. (NYSE:STJ) announced today it has signed a definitive agreement to acquire the business of Velocimed, LLC ("Velocimed"), a …See details»
St. Jude Medical Acquires Interventional Cardiology Company
March 1, 2005. 2 Min Read. Continuing a buying spree that began last summer, St. Jude Medical Inc. (St. Paul, MN) has announced a definitive agreement to acquire Velocimed …See details»
St. Jude Medical acquires Velocimed - 2005-02-15 - Crunchbase
Feb 15, 2005 Velocimed Velocimed was founded by a group of well known medical entrepreneurs. Acquiring Organization: St. Jude Medical St. Jude Medical is a medical …See details»
Velocimed offers third way in embolic protection:
04 Apr 2003. News. Executive Summary. The receipt by Minneapolis, Minnesota-based Velocimed of a CE mark for its embolic protection device, Proxis, means physicians in …See details»
St. Jude Announces Agreement to Acquire Velocimed | FDAnews
St. Jude Medical has signed a definitive agreement to acquire the business of Velocimed, a privately owned company located in Maple Grove, Minn., that develops and …See details»
Velocimed, Inc | VentureRadar
Velocimed, Inc VentureRadar profile. Find out more about Velocimed, Inc including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
St. Jude Completes Acquisition of Velocimed | FDAnews
Apr 8, 2005 St. Jude Medical announced it has completed the acquisition of the business of Velocimed, a privately owned company that develops, manufactures and markets …See details»
Velocimed - Ownership and Business Overview | Mergr
Feb 15, 2005 Yes. Velocimed was formerly owned by 1 private investor. Velocimed Business Overview. Where is Velocimed headquartered? Velocimed is headquartered …See details»
Velocimed, LLC - Rivervest
/ PORTFOLIO. Minneapolis, MN. Velocimed developed multiple unique interventional cardiology products, including a proximal embolic protection device (Proxisâ„¢), a patent …See details»
Velocimed - Products, Competitors, Financials, Employees, …
Overview & Products. Financials. People. Founded Year. 2001. Stage. Acquired | Acquired. Total Raised. $46.5M. About Velocimed. Developer, manufacturer, and marketer of …See details»
The PROXIMAL Trial: Proximal Protection During ... - ScienceDirect
Oct 9, 2007 A complete list of the PROXIMAL investigators and study organization appears in the Appendix. This trial was funded by St. Jude Medical, formerly known as …See details»
Lessons Learned from Carotid Flow Diversion for Stroke …
Had a financial interest/arrangement or affiliation with the organization listed below. ... •Terumo Consultant •Cierra Consultant •Velocimed Consultant •Cordis Consultant …See details»
Velocimed | Evaluate
The latest news, comment and analysis about Velocimed from the Vantage editorial team.See details»
Percutaneous closure of patent foramen ovale with a novel …
Jan 9, 2014 He also has stock options and/or stocks in the following companies: Cardiokinetix, Access Closure, Velocimed, Cierra, CoAptus and Lumen Biomedical. …See details»
Dennis W. Wahr - Board of Directors, President & CEO
Prior to Lutonix, Dr. Wahr co-founded Velocimed in 2001, and served as its President and CEO until its acquisition by St. Jude Medical in 2005. As a company CEO, Dr. Wahr has …See details»
Xtant Medical Announces Changes to Its Executive Management …
Jun 16, 2016 He has also served on the Board of Directors for businesses including SentreHEART,Sunshine Heart, Devax, Velocimed, EndiCor, Microvena, Micro …See details»
Velocimed Stock Price, Funding, Valuation, Revenue & Financial …
Apr 3, 2005 MeWe. See Velocimed funding rounds, investors, investments, exits and more. Evaluate their financials based on Velocimed's post-money valuation and revenue.See details»
Velocimed: Drug pipelines, Patents, Clinical trials - Synapse
Last update 02 Aug 2023. Velocimed. Private Company |See details»
Resolution Medical hires industry veteran as CEO
Jun 3, 2020 The Fridley, Minn.–based medical device contract manufacturing and development company noted that Blaeser has 35 years of experience leading teams at …See details»